首页 | 本学科首页   官方微博 | 高级检索  
     


An analysis of FDA-approved drugs for oncology
Affiliation:1. National Key Laboratory of Crop Genetic Improvement, Agricultural Bioinformatics Key Laboratory of Hubei Province, College of Informatics, Huazhong Agricultural University, Wuhan 430070, PR China;2. Institute of Functional Nano & Soft Materials (FUNSOM) and Collaborative Innovation Center of Suzhou Nano Science and Technology, Soochow University, Suzhou, Jiangsu 215123, PR China;3. College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, PR China;1. CFH Beteiligungsgesellschaft mbH, Loehrstrasse 16, 04105 Leipzig, Germany;2. Ilmenau University of Technology, PATON – Landespatentzentrum Thueringen, PF 100 565, 98684 Ilmenau, Germany;1. Madison, WI, USA;2. 410 W. Harrison St, Seattle, WA 98119, USA;3. 602 Samuel Drive, Madison, WI 53717, USA;1. Institute of Law, University of Zurich, Zurich, Switzerland;2. Laboratory for Technology, Markets, and Regulation, University of Zurich, Zurich, Switzerland;3. Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women''s Hospital and Harvard Medical School, Boston, MA, USA;4. Institute of Primary Care, University Hospital Zurich and University of Zurich, Zurich, Switzerland;5. Oncology Department, Hospital de la Santa Creu i Sant Pau, Institut d''Investigació Biomèdica Sant Pau, and Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain;1. Harvard Medical School, Boston, MA, USA;2. Dana-Farber/Boston Children''s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA;1. Center for Research Innovation in Biotechnology, Washington University in St. Louis, St Louis, MO, USA;2. Department of Radiology, Washington University in St. Louis, St Louis, MO, USA
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号